temozolomide has been researched along with 7,3'-dihydroxy-4'-methoxyisoflavone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, H; Fan, Y; Li, Y; Ni, Q; Zhang, X | 1 |
| Fan, H; Fan, Y; Huang, T; Li, J; Li, S; Qiu, R; Zhang, Q; Zhou, Y | 1 |
2 other study(ies) available for temozolomide and 7,3'-dihydroxy-4'-methoxyisoflavone
| Article | Year |
|---|---|
In vitro and in vivo Study on Glioma Treatment Enhancement by Combining Temozolomide with Calycosin and Formononetin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioma; Isoflavones; Mice, Inbred BALB C; Rats; Temozolomide; Wound Healing | 2019 |
The mechanism of formononetin/calycosin compound optimizing the effects of temozolomide on C6 malignant glioma based on metabolomics and network pharmacology.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioma; Humans; Isoflavones; Network Pharmacology; Temozolomide; Tumor Necrosis Factor-alpha | 2022 |